Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP524998.RA6oVDLwyXOL0emZElAqmEuyejyOrgTDPXM_gTjJoGTmM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP524998.RA6oVDLwyXOL0emZElAqmEuyejyOrgTDPXM_gTjJoGTmM130_assertion type Assertion NP524998.RA6oVDLwyXOL0emZElAqmEuyejyOrgTDPXM_gTjJoGTmM130_head.
- NP524998.RA6oVDLwyXOL0emZElAqmEuyejyOrgTDPXM_gTjJoGTmM130_assertion description "[Fifty-two patients with resectable esophageal cancers (cT2-4, Nx, and M0) received neoadjuvant radiochemotherapy (cisplatin, 5-5-fluorouracil, 36 Gy) followed by transthoracic en bloc esophagectomy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524998.RA6oVDLwyXOL0emZElAqmEuyejyOrgTDPXM_gTjJoGTmM130_provenance.
- NP524998.RA6oVDLwyXOL0emZElAqmEuyejyOrgTDPXM_gTjJoGTmM130_assertion evidence source_evidence_literature NP524998.RA6oVDLwyXOL0emZElAqmEuyejyOrgTDPXM_gTjJoGTmM130_provenance.
- NP524998.RA6oVDLwyXOL0emZElAqmEuyejyOrgTDPXM_gTjJoGTmM130_assertion SIO_000772 16322294 NP524998.RA6oVDLwyXOL0emZElAqmEuyejyOrgTDPXM_gTjJoGTmM130_provenance.
- NP524998.RA6oVDLwyXOL0emZElAqmEuyejyOrgTDPXM_gTjJoGTmM130_assertion wasDerivedFrom befree-2016 NP524998.RA6oVDLwyXOL0emZElAqmEuyejyOrgTDPXM_gTjJoGTmM130_provenance.
- NP524998.RA6oVDLwyXOL0emZElAqmEuyejyOrgTDPXM_gTjJoGTmM130_assertion wasGeneratedBy ECO_0000203 NP524998.RA6oVDLwyXOL0emZElAqmEuyejyOrgTDPXM_gTjJoGTmM130_provenance.